GSTM3 and pancreatic neoplasm: On the one hand, GSTM3 influences the malignant metabolic pattern in pancreatic cancer, alleviates aggressiveness in renal cell carcinoma, and reverses radioresistance in hepatocellular carcinoma to suppress tumour malignancy [25–27].